Numeric Investors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1.4M Buy
14,200
+4,000
+39% +$379K 0.01% 697
2017
Q3
$955K Buy
10,200
+6,900
+209% +$733K 0.01% 766
2017
Q2
$367K Sell
3,300
-6,100
-65% -$645K ﹤0.01% 878
2017
Q1
$923K Buy
9,400
+500
+6% +$47.7K 0.01% 664
2016
Q4
$818K Buy
8,900
+2,100
+31% +$181K 0.01% 709
2016
Q3
$575K Buy
+6,800
New +$571K 0.01% 743
2014
Q1
Sell
-24,600
Closed -$1.32M 812
2013
Q4
$1.32M Buy
24,600
+18,400
+297% +$1.09M 0.02% 417
2013
Q3
$383K Buy
+6,200
New +$371K 0.01% 629

Other funds holding DGX

Numeric Investors's DGX Position: Q4 2017 in Review

Numeric Investors increased its Quest Diagnostics (DGX) stake by 39% in Q4 2017, buying an estimated $379K and bringing the position to 14,200 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #697.

Numeric Investors first reported a position in DGX in Q3 2013 and has held it in 8 quarters since. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Numeric Investors held 14,200 shares of Quest Diagnostics worth $1.4M as of Q4 2017.
  • Numeric Investors bought 4,000 Quest Diagnostics shares in Q4 2017, an estimated $379K.
  • Quest Diagnostics made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #697 holding.
  • Numeric Investors first reported a position in Quest Diagnostics in Q3 2013 and has held it in 8 quarters since.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.